chr13-48037798-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_018283.4(NUDT15):c.52G>A(p.Val18Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00037 in 1,593,114 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign,drug response (no stars).
Frequency
Genomes: 𝑓 0.00041 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00037 ( 4 hom. )
Consequence
NUDT15
NM_018283.4 missense
NM_018283.4 missense
Scores
1
8
9
Clinical Significance
Conservation
PhyloP100: 8.38
Genes affected
NUDT15 (HGNC:23063): (nudix hydrolase 15) This gene encodes an enzyme that belongs to the Nudix hydrolase superfamily. Members of this superfamily catalyze the hydrolysis of nucleoside diphosphates, including substrates like 8-oxo-dGTP, which are a result of oxidative damage, and can induce base mispairing during DNA replication, causing transversions. The encoded enzyme is a negative regulator of thiopurine activation and toxicity. Mutations in this gene result in poor metabolism of thiopurines, and are associated with thiopurine-induced early leukopenia. Multiple pseudogenes of this gene have been identified. [provided by RefSeq, Apr 2016]
SUCLA2 (HGNC:11448): (succinate-CoA ligase ADP-forming subunit beta) Succinyl-CoA synthetase (SCS) is a mitochondrial matrix enzyme that acts as a heterodimer, being composed of an invariant alpha subunit and a substrate-specific beta subunit. The protein encoded by this gene is an ATP-specific SCS beta subunit that dimerizes with the SCS alpha subunit to form SCS-A, an essential component of the tricarboxylic acid cycle. SCS-A hydrolyzes ATP to convert succinate to succinyl-CoA. Defects in this gene are a cause of myopathic mitochondrial DNA depletion syndrome. A pseudogene of this gene has been found on chromosome 6. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009341568).
BP6
Variant 13-48037798-G-A is Benign according to our data. Variant chr13-48037798-G-A is described in ClinVar as [Likely_benign, drug_response]. Clinvar id is 225203.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 62 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUDT15 | NM_018283.4 | c.52G>A | p.Val18Ile | missense_variant | 1/3 | ENST00000258662.3 | NP_060753.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUDT15 | ENST00000258662.3 | c.52G>A | p.Val18Ile | missense_variant | 1/3 | 1 | NM_018283.4 | ENSP00000258662.1 | ||
SUCLA2 | ENST00000646804.1 | c.-277C>T | 5_prime_UTR_variant | 1/11 | ENSP00000493977.1 | |||||
SUCLA2 | ENST00000643246.1 | c.-355C>T | 5_prime_UTR_variant | 1/3 | ENSP00000496235.1 |
Frequencies
GnomAD3 genomes AF: 0.000420 AC: 64AN: 152236Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
64
AN:
152236
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000912 AC: 193AN: 211708Hom.: 3 AF XY: 0.000886 AC XY: 101AN XY: 113942
GnomAD3 exomes
AF:
AC:
193
AN:
211708
Hom.:
AF XY:
AC XY:
101
AN XY:
113942
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000366 AC: 527AN: 1440760Hom.: 4 Cov.: 31 AF XY: 0.000375 AC XY: 268AN XY: 714488
GnomAD4 exome
AF:
AC:
527
AN:
1440760
Hom.:
Cov.:
31
AF XY:
AC XY:
268
AN XY:
714488
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000407 AC: 62AN: 152354Hom.: 1 Cov.: 33 AF XY: 0.000389 AC XY: 29AN XY: 74496
GnomAD4 genome
AF:
AC:
62
AN:
152354
Hom.:
Cov.:
33
AF XY:
AC XY:
29
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
101
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Likely benign; drug response
Submissions summary: Benign:1Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
NUDT15-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 11, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Thiopurines, poor metabolism of, 2 Other:1
drug response, no assertion criteria provided | literature only | OMIM | Oct 25, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
T
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at